Early Rhythm Control May Be Cost-Effective in Atrial Fibrillation Care
A cost-effectiveness analysis of the EAST – AFNET 4 trial indicated the health benefits of early rhythm control come at reasonable additional costs compared to usual care.
Stay updated with breaking news from Eppendorf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A cost-effectiveness analysis of the EAST – AFNET 4 trial indicated the health benefits of early rhythm control come at reasonable additional costs compared to usual care.
Germany: Thrombectomy appears to be a safe and feasible treatment option for a rare stroke type with clinical outcomes comparable to the best medical treatment with and without IV (intravenous)...
Global Lab Automation Market Size, Growth, Opportunities Analysis & Forecast to 2022-2028 Bharat Book Bureau Provides the Trending Market Research…
Automated Liquid Handling Market report begins with the purpose of offering insights into the market forecast, market features, end-user market,
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Single-Use Bio Reactors Global Market Report 2023" report has been added to ResearchAndMarkets.com's...